Home > Journals > Minerva Oftalmologica > Past Issues > Minerva Oftalmologica 2012 June;54(2) > Minerva Oftalmologica 2012 June;54(2):69-73

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA OFTALMOLOGICA

A Journal on Ophthalmology


eTOC

 

REVIEWS  


Minerva Oftalmologica 2012 June;54(2):69-73

language: Italian

The compliance role in glaucoma therapy

Actis A. G., Penna R., Brogliatti B., Rolle T.

Sezione di Oftalmologia, Clinica Oculistica, Dipartimento di Fisiopatologia Clinica, Università degli Studi di Torino, Torino, Italia


PDF  


The number of studies that investigate compliance in glaucoma is consistent and has increased dramatically in recent years, confirming the growing interest in this topic. The available literature data show how often antiglaucomatous therapy is managed by the patient in a suboptimal way: adherence is therefore a common problem for many glaucoma patients, especially for those newly diagnosed. In our review we analyze this issue with particular reference to risk factors associated with poor compliance: they are still often poorly defined and understood, and while some of them reach unanimous agreement in the literature, others seem to play a controversial role. The problem, which recognizes a multifactorial genesis, requires a personalized approach based on the characteristics of each patient.

top of page

Publication History

Cite this article as

Corresponding author e-mail